Eleva Capital SAS
PARIS, I0
$343m in 24 US stocks at the end of 30 June 2026. The top 10 are 97.6% of the money. It changed about 0.0% of the portfolio this quarter.
Value
$343m
Stocks
24
Top 10 share
97.6%
Turnover
0.0%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
None this quarter.
Holdings
- Esperion Therapeutics INC NE
- Share
- 0.1%
- Value
- $501,549
- Shares
- 183,047
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| CRH PublicCRH | 81.3% | $279m | 2,654,974 | Held |
| Amer SportsAS | 2.9% | $10m | 298,802 | Held |
| NvidiaNVDA | 2.6% | $9m | 52,002 | Held |
| NetflixNFLX | 2.4% | $8m | 87,190 | Held |
| AlphabetGOOGL | 2.3% | $8m | 27,967 | Held |
| Taiwan Semiconductor ManufacturingTSM | 1.9% | $7m | 21,411 | Held |
| Arista NetworksANET | 1.7% | $6m | 46,957 | Held |
| Amazon.comAMZN | 1.0% | $3m | 16,155 | Held |
| T-Mobile USTMUS | 0.9% | $3m | 14,347 | Held |
| Robinhood MarketsHOOD | 0.6% | $2m | 31,625 | Held |
| On Holding AGONON | 0.5% | $2m | 50,150 | Held |
| Boston ScientificBSX | 0.5% | $2m | 26,667 | Held |
| Spotify TechnologySPOT | 0.4% | $1m | 2,715 | Held |
| NewAmsterdam PharmaNAMS | 0.2% | $823,329 | 25,721 | Held |
| CG OncologyCGON | 0.2% | $561,000 | 8,289 | Held |
| Esperion Therapeutics INC NE | 0.1% | $501,549 | 183,047 | Held |
| Mineralys TherapeuticsMLYS | 0.1% | $462,724 | 17,081 | Held |
| Fennec PharmaceuticalsFENC | <0.1% | $327,389 | 53,234 | Held |
| Disc MedicineIRON | <0.1% | $327,053 | 5,115 | Held |
| Viridian TherapeuticsVRDN | <0.1% | $139,385 | 7,126 | Held |
| Freeport-McMoRanFCX | <0.1% | $132,725 | 2,258 | Held |
| Archer AviationACHR | <0.1% | $111,331 | 21,534 | Held |
| Edgewise TherapeuticsEWTX | <0.1% | $54,990 | 17,460 | Held |
| Aquestive TherapeuticsAQST | <0.1% | $11,288 | 2,720 | Held |
Over time and by industry
Value over time
Sep '25
Jun '26
Value is down 25.9% since 30 June 2025.
Where the money is
Materials81.3%
Technology6.2%
Media & telecom6.0%
Retail & consumer4.3%
Health care1.3%
Financial services0.6%
Industrials0.0%
Other0.1%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.